Protalix Biotherapeutics, Inc. (PLX)
2.04
-0.02
(-0.97%)
USD |
NYAM |
Jan 16, 16:00
2.05
+0.01
(+0.49%)
After-Hours: 20:00
Protalix Biotherapeutics Shareholders Equity (Quarterly): 52.91M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| OraSure Technologies, Inc. | 361.98M |
| PAVmed, Inc. | 35.78M |
| Denali Therapeutics, Inc. | 926.20M |
| AIM ImmunoTech, Inc. | -6.077M |
| Armata Pharmaceuticals, Inc. | -95.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.26M |
| Total Liabilities (Quarterly) | 29.36M |
| Debt to Equity Ratio | 0.1546 |
| Current Ratio | 3.030 |
| Net Debt Paydown Yield | 2.02% |